PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-65.20%
Both yoy net incomes decline, with EQT at -10.14%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-5.11%
Negative yoy D&A while EQT is 2.24%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
285.96%
Some yoy growth while EQT is negative at -100.96%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
74.00%
Slight usage while EQT is negative at -2774.75%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.00%
Some yoy usage while EQT is negative at -1037.37%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-92.71%
Both negative yoy, with EQT at -177.98%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-15.63%
Both yoy CFO lines are negative, with EQT at -194.92%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-16.17%
Both yoy lines negative, with EQT at -7.68%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.74%
We reduce yoy other investing while EQT is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-510.35%
Both yoy lines negative, with EQT at -7.68%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-90.48%
Negative yoy issuance while EQT is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.